Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Schizophrenia

Free Subscription 26.02.2024 1 Acta Psychiatr Scand 1 Brain Res 1 Can J Psychiatry 1 Mol Psychiatry 1 Pharmacopsychiatry 5 Psychiatry Res 1 Psychol Med 9 Schizophr Res

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Psychiatr Scand

1. BERGQVIST J, Hedskog S, Hedman C, Schultz T, et al
   Patients with both cancer and psychosis-to what extent do they receive specialized palliative care.
   Acta Psychiatr Scand. 2024 Feb 18. doi: 10.1111/acps.13666.
   PubMed         Abstract available
   
   

   
   Brain Res

2. LIN P, Zhu G, Xu X, Wang Z, et al
   Brain network analysis of working memory in schizophrenia based on multi graph attention network.
   Brain Res. 2024 Feb 20:148816. doi: 10.1016/j.brainres.2024.148816.
   PubMed         Abstract available
   
   

   
   Can J Psychiatry

3. L'HEUREUX S, Huot-Lavoie M, Bergeron A, Bergeron C, et al
   Effect of Cannabis Legalization in Canada on the Incidence of Psychosis Consultations in Quebec City's Psychiatric Emergency Services.
   Can J Psychiatry. 2024 Feb 21:7067437241232901. doi: 10.1177/07067437241232901.
   PubMed        
   
   

   
   Mol Psychiatry

4. FOUNTOULAKIS KN, Tsapakis EM
   Neither serotonin disorder is at the core of depression nor dopamine at the core of schizophrenia; still these are biologically based mental disorders.
   Mol Psychiatry. 2024 Feb 19. doi: 10.1038/s41380-024-02458.
   PubMed        
   
   

   
   Pharmacopsychiatry

5. HART XM, Mitsukura Y, Bies RR, Uchida H, et al
   Unraveling the Influence of Age, IQ, Education, and Negative Symptoms on Neurocognitive Performance in Schizophrenia: A Conditional Inference Tree Analysis.
   Pharmacopsychiatry. 2024 Feb 22. doi: 10.1055/a-2258-0379.
   PubMed         Abstract available
   
   

   
   Psychiatry Res

6. KIKUCHI Y, Komatsu H, Otsuka Y, Ito F, et al
   Effect of concomitant use of valproic acid during clozapine initiation on clozapine-induced inflammation among Japanese patients with schizophrenia.
   Psychiatry Res. 2024;334:115810.
   PubMed         Abstract available
   
   
7. GOODING DC, Mohrbacher DA, Umucu E, Van Hulle CA, et al
   Ethnoracialized group differences in attitudes and knowledge about schizophrenia and willingness to engage in biomarker research: The UBIGR Study.
   Psychiatry Res. 2024;334:115776.
   PubMed         Abstract available
   
   
8. HYATT AS, Mulvaney-Day N, Chow CM, Cook BL, et al
   Association between electronic nicotine product use and subsequent first episode psychosis.
   Psychiatry Res. 2024;334:115785.
   PubMed         Abstract available
   
   
9. QUIRINO AHA, da Rocha MEC, Andrade AGM, E Souza FGM, et al
   The demonstrated association: Cannabis use and onset of psychosis in the study by Medeiros et al., refuting the reverse notion.
   Psychiatry Res. 2024;334:115771.
   PubMed        
   
   
10. KISHI T, Citrome L, Sakuma K, Iwata N, et al
    A comparison of recurrence rates after discontinuation of second-generation antipsychotic long-acting injectable versus corresponding oral antipsychotic in the maintenance treatment of bipolar disorder: A systematic review.
    Psychiatry Res. 2024;333:115761.
    PubMed         Abstract available
    
    

    
    Psychol Med

11. SIMONSEN C, Asbo G, Slade M, Wold KF, et al
    A good life with psychosis: rate of positive outcomes in first-episode psychosis at 10-year follow-up.
    Psychol Med. 2024 Feb 23:1-10. doi: 10.1017/S0033291724000205.
    PubMed         Abstract available
    
    

    
    Schizophr Res

12. MILEY K, Bronstein MV, Ma S, Lee H, et al
    Trajectories and predictors of response to social cognition training in people with schizophrenia: A proof-of-concept machine learning study.
    Schizophr Res. 2024;266:92-99.
    PubMed         Abstract available
    
    
13. IMAM I, Johnson KA, Saluja A, Mesholam-Gately RI, et al
    Advancing equity & access for psychosis care in Massachusetts: Proceedings from the 2023 Mass-STEP Conference.
    Schizophr Res. 2024;266:85-87.
    PubMed        
    
    
14. GURUSAMY J, Gandhi S, Damodharan D, Palaniappan M, et al
    Effect of lifestyle modification intervention (LMI) on metabolic syndrome in schizophrenia in a residential mental health care setting-A mixed method study.
    Schizophr Res. 2024;266:75-84.
    PubMed        
    
    
15. ZAKI JK, Lago SG, Spadaro B, Rustogi N, et al
    Exploring peripheral biomarkers of response to simvastatin supplementation in schizophrenia.
    Schizophr Res. 2024;266:66-74.
    PubMed         Abstract available
    
    
16. BORA E, Eyuboglu MS, Cesim E, Demir M, et al
    Neurocognition and social cognition in youth and young adults at ultra-high-risk for psychosis and bipolar disorder.
    Schizophr Res. 2024;266:58-65.
    PubMed         Abstract available
    
    
17. GARCIA-LEON MA, Fuentes-Claramonte P, Soler-Vidal J, Ramiro-Sousa N, et al
    Cortical volume abnormalities in schizophrenia: Correlations with symptoms and cognitive impairment.
    Schizophr Res. 2024;266:50-57.
    PubMed         Abstract available
    
    
18. EKIN M, Akdal G, Bora E
    Antisaccade error rates in first-episode psychosis, ultra-high risk for psychosis and unaffected relatives of schizophrenia: A systematic review and meta-analysis.
    Schizophr Res. 2024;266:41-49.
    PubMed         Abstract available
    
    
19. MAAS IL, Bohlken MM, Gangadin SS, Rosema BS, et al
    Personal recovery in first-episode psychosis: Beyond clinical and functional recovery.
    Schizophr Res. 2024;266:32-40.
    PubMed         Abstract available
    
    
20. WARREN N, O'Gorman C, Horgan I, Weeratunga M, et al
    Inflammatory cerebrospinal fluid markers in schizophrenia spectrum disorders: A systematic review and meta-analysis of 69 studies with 5710 participants.
    Schizophr Res. 2024;266:24-31.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge.